These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Clinical Outcome
3 results:

  • 1. Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.
    Ma Y; Chen Y; Petersen I
    Pathol Res Pract; 2017 Dec; 213(12):1568-1574. PubMed ID: 29037838
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib.
    Pommier AJ; Shaw R; Spencer SK; Morgan SR; Hoff PM; Robertson JD; Barry ST; Jürgensmeier JM
    Br J Cancer; 2014 Oct; 111(8):1590-604. PubMed ID: 25121956
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
    Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
    Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.